PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer

Herein, we report the use of a theranostic nanocarrier (Folate-HBPE(CT20p)) to deliver a therapeutic peptide to prostate cancer tumors that express PSMA (folate hydrolase 1). The therapeutic peptide (CT20p) targets and inhibits the chaperonin-containing TCP-1 (CCT) protein-folding complex, is select...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Autores principales: Flores, Orielyz, Santra, Santimukul, Kaittanis, Charalambos, Bassiouni, Rania, Khaled, Amr S, Khaled, Annette R., Grimm, Jan, Perez, J Manuel
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5525751/
https://ncbi.nlm.nih.gov/pubmed/28744329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.18879
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares